Bacterial Identification: Hospital Strategies And Techniques

Bacteria are classified and identified to distinguish between strains and to group them by criteria relevant to microbiologists and other scientists. In hospitals, bacterial identification is crucial to patient safety as hospital-acquired infections are a significant challenge, with an estimated 1.7 million cases in 2002 in the US alone. Healthcare-associated infections are a growing public health problem, with multidrug-resistant bacteria posing a particular threat. To identify bacteria, clinical laboratory scientists employ various tests, technologies, and devices. These include rapid tests, phenotypic or biochemical analyses, molecular platforms, and PCR-based assays. Molecular typing methods are also widely used to identify infectious species for epidemiological studies.

Molecular typing methods

One commonly used molecular typing technique is the polymerase chain reaction (PCR), which allows for the exponential amplification of target DNA. PCR can identify typical bacterial strains that exist in viable but non-culturable forms, often missed by conventional methods. It also helps avoid ambiguous interpretations of phenotypic characteristics. However, PCR may not be suitable for certain foods or samples due to potential inhibition by specific components and sensitivity limitations.

Other molecular typing techniques include pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), random amplified polymorphism deoxyribonucleic acid (RAPD), plasmid profile analysis, and DNA sequencing. These methods have been applied to pathogens isolated from various sources, including environmental samples and foodborne pathogens.

The development of molecular techniques, such as PCR-based methods, has led to an explosion of published genotyping methods for microorganisms. Genotyping is valuable in clinical microbiology and the pharmaceutical sector, providing accurate identification of strains. Additionally, the decreasing costs of next-generation sequencing (NGS) have made whole bacterial genome sequencing more accessible, although data interpretation remains a challenge.

In summary, molecular typing methods provide valuable tools for identifying and characterizing bacteria, particularly in hospital settings for managing nosocomial infections. These methods offer advantages over traditional phenotypic approaches in terms of speed, reproducibility, and the ability to differentiate between closely related species.

Microbiological controls

One key aspect of microbiological control is the identification and detection of pathogenic bacteria. This involves classifying and naming bacteria to distinguish between different organisms and group similar organisms. Bacteria are routinely identified through morphological and biochemical tests, supplemented by specialized tests like serotyping, enzyme typing, and antibiotic inhibition patterns. Molecular typing methods are also widely used to identify infectious species, determine the population structure of microbial communities, and understand genetic diversity within a species.

Another critical component of microbiological control is environmental monitoring and hygiene assessments. This includes evaluating how well surfaces have been cleaned and establishing an aerobic colony count of bacteria. Fluorescent dyes, for instance, can be used to assess if a surface has been adequately cleaned. Additionally, microbial monitoring can help identify specific multi-resistant or virulent pathogens that may be the cause of an outbreak.

To address healthcare-associated infections, hospitals should implement administrative controls. This involves designing spaces and opportunities for individuals to avoid exposure and colonization by pathogens. This approach goes beyond education and training and focuses on modifying an individual's context so that their default decisions align with healthy actions. For example, providing handwashing stations or antiseptic alcohol at the exits of patient rooms and implementing one-way human traffic flows can minimize exposure to healthcare workers and other patients, reducing contamination.

Clinical laboratory identification

One common method used in clinical laboratories is molecular typing, which involves various techniques such as multiplex polymerase chain reaction (M-PCR) and genetic probes. M-PCR is a valuable tool for identifying specific bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) strains, by targeting particular genes or genetic sequences. Genetic probes, on the other hand, are commercially available tools that can identify specific virulence factors and bacteria. They are widely used for detecting Mycobacterium tuberculosis and the M. avium complex, as well as Neisseria gonorrhoeae and Chlamydia trachomatis directly from clinical specimens.

In addition to molecular methods, clinical laboratories use biochemical and phenotypic analyses for bacterial identification. This includes evaluating antimicrobial susceptibility patterns, where the bacteria are exposed to different antibiotics to determine their sensitivity. This approach guides the selection of the most effective antibiotic treatment for the patient. Biochemical tests may also involve assessing biofilm formation, which is relevant in hospital-acquired pneumonia cases, as biofilms can contribute to antimicrobial resistance and pathogen recurrence.

Furthermore, morphological tests play a role in bacterial identification. This includes observing the shape of bacteria, which can be spheres (cocci), rods (bacilli), or spirals (spirochetes). Additionally, the Gram stain test categorizes bacteria as gram-positive or gram-negative based on their cell wall structure and colouration under the stain. This classification is essential as gram-positive and gram-negative bacteria cause different types of infections and require distinct treatment approaches.

While clinical laboratories have a range of tools for bacterial identification, challenges arise with atypical, rare, or newly discovered bacterial species. Misidentification can occur, emphasizing the need for laboratory personnel to stay updated on taxonomic changes and new species recognition. Commercial identification systems, both FDA-approved and non-FDA-approved, also face difficulties in keeping pace with the rapid expansion of bacterial taxonomy and incorporating new species into their databases.

Innovative molecular methods

One notable challenge is the difficulty in incorporating newly proposed species, especially those of environmental origin, into commercial product databases. This issue is further exacerbated when the cumulative number of known strains per taxon is relatively low. Additionally, the curation of these databases varies significantly, and the quality of public or private databases associated with commercial products may not always be up to par. As a result, laboratories must be cautious about incorrect identifications and have backup systems in place to ensure accurate results.

Molecular typing methods play a crucial role in identifying infectious species for epidemiological studies and understanding the population structure of microbial communities. These methods are particularly useful in hospital settings, where nosocomial infections, such as hospital-acquired pneumonia (HAP), are a significant concern. By employing molecular typing, researchers can determine the genetic diversity within a bacterial species and implement targeted treatment approaches.

Furthermore, innovative molecular methods have led to the development of specific genetic probes for identifying virulence factors and various bacteria and viruses. Genetic probes are commonly used for the identification of Mycobacterium tuberculosis and the M. avium complex in the United States. They are also being utilised directly on clinical specimens for Neisseria gonorrhoeae and Chlamydia trachomatis with excellent sensitivity and specificity, providing same-day results. The development of these innovative molecular methods has greatly enhanced the accuracy and efficiency of bacterial identification in hospital settings.

Bacterial identification strategies

Bacterial identification is a critical aspect of healthcare, as it enables the accurate diagnosis and treatment of bacterial infections. While most bacteria are harmless or even beneficial to our health, certain types can cause diseases and infections. Therefore, accurate identification of bacteria is crucial for effective patient care. Here are some strategies used for bacterial identification in hospitals:

Phenotypic and Biochemical Analyses

This method involves examining the physical and biochemical characteristics of bacteria. It includes observing the shape, size, and colour of bacteria under a microscope. Scientists classify bacteria into three basic shapes: cocci (spheres), bacilli (rod-shaped), and spirochetes (spiral or helix-shaped). They also categorise bacteria as gram-positive or gram-negative based on their cell wall structure and their appearance under a Gram stain. Additionally, biochemical tests are performed to identify specific enzymes, toxins, or other virulence factors produced by the bacteria.

Molecular Platforms and PCR-based Assays

Molecular methods, including PCR (polymerase chain reaction) tests, have revolutionised bacterial identification. PCR-based assays can identify bacteria by amplifying and analysing specific genetic sequences. These assays have been commercially developed and FDA-approved, contributing to the rapid and accurate identification of pathogens. Molecular platforms, such as mass spectrometry, also play a significant role in bacterial identification by analysing the genetic makeup of bacteria.

Rapid Tests

Rapid tests are crucial for timely diagnosis and treatment, especially in urgent cases. These tests can provide quick results, helping healthcare providers make immediate decisions about patient care. Rapid tests may include preliminary screenings or point-of-care tests that can be performed at the patient's bedside or in outpatient settings.

Epidemiological and Molecular Typing Methods

Identifying the predominant bacterial types in a specific region or hospital is essential for epidemiological purposes. Molecular typing methods, such as SCCmec typing for MRSA strains, are widely used to identify infectious species and determine the population structure of microbial communities. This information helps in understanding the genetic diversity within a species and contributes to epidemiological studies.

Antimicrobial Susceptibility Testing

Once a bacterial infection is identified, determining its sensitivity to different antibiotics is crucial. This involves exposing the bacterial sample to various antibiotics and observing which one causes the most damage to the bacteria. This information guides the selection of the most effective antibiotic for treating the infection.

Backup Identification Systems

Despite advancements in technology, no single identification system is perfect, and incorrect results can occur. Therefore, laboratories should have backup systems in place that use substantially different methodologies to ensure accurate identification when needed. Difficult-to-identify bacteria can also be submitted to commercial or reference centres for final identification using more sophisticated methods.

Frequently asked questions